ArticleBMJ open2026
Exploring the psychological impact and healthcare experiences of patients living with
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMultiple myeloma (MM) is a chronic haematological malignancy caused by the proliferation of malignant plasma cells in the bone marrow and overproduction of monoclonal antibodies. While no cure is available, treatments aim to control the disease and place patients into remission. AIMS AND
objectivesThis research aimed to explore the psychological impact and healthcare experiences of patients affected by triple-class refractory (TCR) MM. This research formed part of a wider qualitative study examining the experiences of newly diagnosed, double-class exposed and TCRMM patients.
methodsThis qualitative, semi-structured interview study using Interpretative Phenomenological Analysis examined patient experiences. Patients were recruited through Myeloma UK, a charity for patients with MM and carers.
resultsSeven patients diagnosed with TCRMM (five men and two women), aged 41-84 years (
conclusionsThe results demonstrate the psychological burden of TCRMM and the associated treatments across patient management and/or care. Likewise, patient access to informative materials and practical tools to support engagement in informed decision-making, specifically around treatments and clinical trials, needs to be more routinely offered and made available.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.